Jennifer Tousignant
About Jennifer Tousignant
Jennifer Tousignant is a seasoned legal executive with extensive experience in the biotechnology industry, specializing in a wide range of technologies and therapeutic categories.
Jennifer Tousignant Company
Jennifer Tousignant has held influential roles at various biotechnology companies. She is currently the Chief Legal Officer with an extensive background in addressing the legal and compliance needs of organizations in the biotech sector. Her experience spans across leadership positions at Sana Biotechnology, Inc., Xilio Therapeutics, and TESARO, Inc., each with significant contributions to their legal, strategic, and business operations. Additionally, she was an integral part of Genzyme Corporation before its acquisition by Sanofi.
Jennifer Tousignant Title and Current Role
Jennifer Tousignant serves as the Chief Legal Officer in the biotechnology industry. In her current capacity, she leverages her extensive legal expertise to provide comprehensive support in various legal matters, from intellectual property to corporate governance, across the company spectrum. Her role involves detailed oversight and leadership in navigating the complex legal landscape of biotechnology.
Jennifer Tousignant Education and Expertise
Jennifer Tousignant holds a Juris Doctor (JD) degree from Suffolk University School of Law, graduated magna cum laude. She also earned a Bachelor of Arts (BA) in Chemistry with Honors from the University of Virginia. Her educational background has equipped her with the scientific knowledge and the legal acumen necessary to excel in the biotechnology legal field, particularly in areas such as small molecules, biologics, and gene therapies.
Jennifer Tousignant Background in Biotechnology Legal Management
Jennifer Tousignant's career in biotechnology legal management includes significant roles at leading biotech firms. At Sana Biotechnology, Inc., she was the Senior Vice President of Legal, directing teams focused on strategic transactions, business development, intellectual property, and more. At Xilio Therapeutics, she handled all legal and compliance matters. During her tenure at TESARO, Inc., she established and managed the intellectual property function, playing vital roles in product launches and the company’s acquisition by GSK. Her experience also includes substantial roles at Genzyme Corporation, where she led a global legal team and supported vital business units in rare disease and multiple sclerosis.
Jennifer Tousignant Achievements in Biotechnology
Throughout her career, Jennifer Tousignant has made significant contributions to the biotechnology sector. At TESARO, Inc., she was notable for her work in building the intellectual property function, partaking in global launch teams for several products, and facilitating the company's acquisition by GSK. At Genzyme Corporation, she served key roles from research transitions to legal leadership, shaping the IP strategies for various pivotal products. Her role at Sana Biotechnology, Inc., encompassed a vast range of legal support activities, ensuring compliance and strategic alignment in business operations.